BrightSpring Q1 revenue up 26% to $3.6B; raises FY 2026 EBITDA guidance to $795M-$825M

BrightSpring Health Services, Inc.

2026-Q1 EPS reported $0.67 revenue$3,613,721,000

Net income $74M vs $9M a year ago; Adjusted EBITDA $190M, up 45% YoY from $131M.
Pharmacy Solutions revenue $3,171M (+25%), Provider Services revenue $442M (+28%).
Community Living divestiture closed March 30; $31.2M gain on sale recorded in discontinued ops.
FY 2026 guidance raised: Revenue $14.7B-$15.2B (14-18% growth), EBITDA $795M-$825M (29-34% growth).
Leverage improved to 2.27x from pro forma 2.60x at year-end 2025.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

BrightSpring Health Services, Inc. reported the quarter ended March 31, 2026 results: revenue $3,614 million, net income $74 million. Guidance raised.

Period: the quarter ended March 31, 2026
Revenue: $3,614 million
Net income: $74 million
Guidance: raised
Result: reported results

Exact text from the filing

EBITDA 1 guidance. First Quarter 2026 Financial Highlights (note: all figures represent continuing operations and exclude the Community Living business) • Net revenue of $3,614 million, up 25.6% compared to $2,878 million in the first quarter of 2025 • Gross profit of $482 million, up 42.5% compared to $338 million in the first quarter of 2025 • Net income of

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

BrightSpring Health Services, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-198983

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.